Pcv13 vaccine im
This code is not in the latest file (4Q26). It was last listed in 4Q25.
Payment limit per 0.5 ML, by effective quarter, 1Q21 to 4Q25. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.This code is not in the latest file (4Q26). It was last listed in 4Q25.
Payment limit per 0.5 ML, by effective quarter, 1Q21 to 4Q25. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.No NDCs mapped to this code in the 4Q26 crosswalk.
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q25 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted September 8, 2026 |
| 3Q25 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted March 10, 2026 |
| 2Q25 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted March 10, 2026 |
| 1Q25 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted December 19, 2025 |
| 4Q24 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 11, 2025 |
| 3Q24 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 11, 2025 |
| 2Q24 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted March 11, 2025 |
| 1Q24 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted December 19, 2024 |
| 4Q23 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted October 10, 2024 |
| 3Q23 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 5, 2024 |
| 2Q23 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted February 23, 2024 |
| 1Q23 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted December 6, 2023 |
| 4Q22 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 22, 2023 |
| 3Q22 | $257.989 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 9, 2023 |
| 2Q22 | $257.989 | +$16.606 | 0.5 ML | Pcv13 vaccine im | v1, posted December 14, 2022 |
| 1Q22 | $241.383 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 8, 2022 |
| 4Q21 | $241.383 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 2, 2022 |
| 3Q21 | $241.383 | $0.00 | 0.5 ML | Pcv13 vaccine im | v1, posted June 2, 2022 |
| 2Q21 | $241.383 | +$11.242 | 0.5 ML | Pcv13 vaccine im | v1, posted March 1, 2022 |
| 1Q21 | $230.141 | – | 0.5 ML | Pcv13 vaccine im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.